Intraocular Melanoma
Showing 1 - 25 of 33
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,
Completed
- Acral Lentiginous Malignant Melanoma
- +10 more
- cediranib maleate
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jul 27, 2018
Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Pittsburgh (Peptide vaccine, GM-CSF, PF3512676)
Completed
- Intraocular Melanoma
- +2 more
- Peptide vaccine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Jun 21, 2017
Intraocular Melanoma, Malignant Conjunctival Tumor Trial run by the CC (cyclophosphamide, lenalidomide, sunitinib malate)
Terminated
- Intraocular Melanoma
- Malignant Conjunctival Neoplasm
- cyclophosphamide
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Feb 6, 2017
Intraocular Melanoma, Melanoma (Skin) Trial in New York (biological, device, other)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- mouse gp100 plasmid DNA vaccine
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 26, 2017
Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Charlottesville (incomplete Freund's adjuvant,
Completed
- Intraocular Melanoma
- +2 more
- incomplete Freund's adjuvant
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Dec 15, 2016
Intraocular Melanoma Trial in Columbus (nab-paclitaxel)
Completed
- Intraocular Melanoma
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 14, 2016
Tumor Samples in Patients Undergoing Radiation Therapy or
Completed
- Intraocular Melanoma
- fluorescence in situ hybridization
- +4 more
-
Cleveland, OhioCleveland Clinic Cole Eye Institute
Jan 28, 2015
Intraocular Melanoma, Melanoma (Skin) Trial in Charlottesville (incomplete Freund's adjuvant, multi-epitope melanoma peptide
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- incomplete Freund's adjuvant
- +2 more
-
Charlottesville, VirginiaCancer Center at the University of Virginia
Dec 18, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Charlottesville (IFA, 6MHP, GM-CSF)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- IFA
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Nov 18, 2014
Brain and CNS Tumors, Childhood Langerhans Cell Histiocytosis, Gastrointestinal Carcinoid Tumor Trial in New Haven (indium In
Terminated
- Brain and Central Nervous System Tumors
- +11 more
- indium In 111 pentetreotide
-
New Haven, ConnecticutYale Comprehensive Cancer Center
Jul 1, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Terminated
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +4 more
-
Los Angeles, California
- +1 more
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Duarte, Los Angeles (gp100 antigen, incomplete Freund's adjuvant, recombinant
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- gp100 antigen
- +3 more
-
Duarte, California
- +1 more
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (biological, drug, procedure)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +7 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +5 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles, Ann Arbor (MART-1 antigen, gp100:209-217(210M) peptide vaccine,
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +3 more
-
Los Angeles, California
- +1 more
May 19, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Tampa (Autologous Dendritic Cells (DC), Fludarabine, Autologous Lymphocyte
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- Autologous Dendritic Cells (DC)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Feb 20, 2014
Intraocular Melanoma Trial in Encinitas (cisplatin, sunitinib malate, tamoxifen citrate)
Unknown status
- Intraocular Melanoma
- cisplatin
- +3 more
-
Encinitas, CaliforniaSan Diego Pacific Oncology and Hematology Associates, Incorporat
Jan 9, 2014
Genes and Environment in Cancer in East Anglia, Trent, or West
Unknown status
- Bladder Cancer
- +8 more
- DNA analysis
- +3 more
-
Cambridge, England, United KingdomUniversity of Cambridge Cancer Research UK
Aug 23, 2013
Intraocular Melanoma Trial in Paris (biological, drug, genetic, other)
Unknown status
- Intraocular Melanoma
- bevacizumab
- +3 more
-
Paris, FranceInstitut Curie Hopital
Aug 23, 2013
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (iodine I 131 mAb 3F8)
Completed
- Brain and Central Nervous System Tumors
- +6 more
- iodine I 131 monoclonal antibody 3F8
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 1, 2013
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- gp100 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- aldesleukin
- ipilimumab
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Intraocular Melanoma, Melanoma (Skin) Trial in New York (temozolomide, thalidomide)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 17, 2013